Latest news with #EUGMP
The Market Online
2 days ago
- Business
- The Market Online
Cannabis Report: Say it, don't spray it
A Canadian psychedelic stock has issued a public warning after discovering that unknown parties are illegally marketing a nasal spray online under false pretenses. The company is urging anyone who may have purchased the product to dispose of it immediately and to report the incident to the appropriate health authorities. (Source: PharmAla Biotech Holdings Inc.) Click here for the full story. 1 | MediPharm Labs closes $4.5 Million sale of Hope, BC facility and announces plans to expand EU GMP cultivation capacity at Napanee facility 2 | 1933 Industries completion purchase of 9 per cent interest of cultivation and production subsidiary 3 | Simply Solventless reports 194 per cent gross revenue increase over the prior year Top Cannabis Stocks May 30 to June 05, 2025 1. | 9,388 views | Medipharm Labs Corp. 2. | 5,276 views | Canopy Growth Corp. 3. | 5,021 views | Tilray Brands Inc. 4. | 4,432 views | Curaleaf Holdings Inc. 5. | 627 views | Nextleaf Solutions Ltd. 6. | 517 views | Organigram Holdings Inc. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Hamilton Spectator
02-05-2025
- Business
- Hamilton Spectator
Village Farms International Reschedules Q1 2025 Conference Call
VANCOUVER, British Columbia, May 02, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ('Village Farms' or the 'Company') (NASDAQ: VFF) today announced it has rescheduled its previously announced conference call to discuss its first quarter 2025 financial results to Tuesday, May 13, 2025, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms First Quarter 2025 Conference Call Webcast or on the Company website at Village Farms - Events . Participants wanting to access the conference call by telephone must register in advance at Village Farms First Quarter 2025 Conference Call Registration to receive telephone dial-in information. The live question and answer session will be limited to analysts; however, others are invited to submit questions ahead of the conference call via email at investorrelations@ . Management will address questions received via email during the question and answer session as time permits. The Company will report its first quarter 2025 financial results via news release on Monday, May 12, 2025 after market close. Conference Call Archive Access Information For those unable to participate in the conference call at the scheduled time, it will be archived for replay beginning approximately one hour following completion of the call on Village Farms' web site at . About Village Farms International, Inc. Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods. The Company has a strong foundation as the leading and longest-tenured leading fresh produce supplier to grocery and large-format retailers throughout the US and Canada and is capitalizing on new high-growth opportunities in the cannabis and CBD categories in North America, the Netherlands and selected markets internationally. In Canada, the Company's wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of Canada's best-selling brands. The Company also owns 80% of Québec-based, Rose LifeScience, a leading third-party cannabis products commercialization expert in the Province of Québec. Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential. The Company exports medical cannabis from its EU GMP certified facility in Canada to a growing list of international markets including Germany, the United Kingdom, Israel, and Australia. The Company is expanding its international presence with additional export contracts to new countries and customers in the Asia-Pacific and European regions, as well as select strategic investments in operating assets. In Europe, wholly-owned Leli Holland has one of 10 licences to grow and distribute recreational cannabis products. In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD and hemp-derived brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms' cannabis success in Canada. Village Farms Clean Energy (VFCE), through a partnership with Atlanta-based Terreva Renewables, creates clean energy from landfill gas at its Delta RNG facility. VFCE receives royalties on all revenue generated. This partnership reduces Vancouver's greenhouse gas emissions by 475,000 metric tons of CO2 per year, equivalent to removing more than 100,000 vehicles off the road or the energy use equivalent of powering 51,300 homes for one year. Cautionary Statement Regarding Forward-Looking Information As used in this Press Release, the terms 'Village Farms', 'Village Farms International', the 'Company', 'we', 'us', 'our' and similar references refer to Village Farms International, Inc. and our consolidated subsidiaries, and the term 'Common Shares' refers to our common shares, no par value. Our financial information is presented in U.S. dollars and all references in this Press Release to '$' means U.S. dollars and all references to 'C$' means Canadian dollars. This Press Release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), and is subject to the safe harbor created by those sections. This Press Release also contains 'forward-looking information' within the meaning of applicable Canadian securities laws. We refer to such forward-looking statements and forward-looking information collectively as 'forward-looking statements'. Forward-looking statements may relate to the Company's future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable or produce industry, the cannabis industry and market and our energy segment are forward-looking statements. In some cases, forward-looking information can be identified by such terms as 'can', 'outlook', 'may', 'might', 'will', 'could', 'should', 'would', 'occur', 'expect', 'plan', 'anticipate', 'believe', 'intend', 'try', 'estimate', 'predict', 'potential', 'continue', 'likely', 'schedule', 'objectives', or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Press Release are subject to risks that may include, but are not limited to: our limited operating history in the cannabis and cannabinoids industry, including that of Pure Sunfarms, Corp. ('Pure Sunfarms'), Rose LifeScience Inc. ('Rose' or 'Rose LifeScience') and Balanced Health Botanicals, LLC ('Balanced Health'); the limited operational history of the Delta RNG Project in our energy segment; the legal status of the cannabis business of Pure Sunfarms and Rose and the hemp business of Balanced Health and uncertainty regarding the legality and regulatory status of cannabis in the United States; risks relating to the integration of Balanced Health and Rose into our consolidated business; risks relating to obtaining additional financing on acceptable terms, including our dependence upon credit facilities and dilutive transactions; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; our market position and competitive position; our ability to leverage current business relationships for future business involving hemp and cannabinoids; the ability of Pure Sunfarms and Rose to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and regarding obtaining and maintaining licenses required under the Cannabis Act (Canada), the Criminal Code and other Acts, S.C. 2018, C. 16 (Canada) for its Canadian operational facilities, and changes in our regulatory requirements; legal and operational risks relating to expected conversion of our greenhouses to cannabis production in Canada and in the United States; risks related to rules and regulations at the U.S. Federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp, cannabidiol-based products commercialization; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; inflationary effects on costs of cultivation and transportation; recessionary effects on demand of our products; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; elevated interest rates; and tax risks. The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Press Release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company's control, which may cause the Company's or the industry's actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company's filings with securities regulators, including the Company's most recently filed Quarterly Report on Form 10-Q and the Company's most recently filed annual report on Form 10-K. When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Press Release relate only to events or information as of the date on which the statements are made in this Press Release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Contact Information Sam Gibbons Senior Vice President, Corporate Affairs Phone: (407) 936-1190 ext. 328 Email: sgibbons@
Yahoo
08-02-2025
- Business
- Yahoo
Inside secret £10m medical cannabis factory guarded by ex-soldiers
These amazing photographs provide a glimpse inside a unique £10 million medicinal cannabis factory in the UK. The top-secret facility is heavily protected by razor wire fencing, bullet-proof glass windows, more than 150 security cameras and a highly trained team of ex-military guards. Run by Derbyshire-based firm Dalgety, the 30,000 sq ft factory produces high-grade cannabinoids for prescription medication. Growing of cannabis for medicinal use was legalised in the UK in 2018. The Midlands site is the first in the UK that holds EU GMP certification to cultivate, manufacture and sell for distribution. READ MORE: BBC's Chris Packham tells gardeners to stop using item as RSPB pulls them from sale READ MORE: Air fryer warning as owners told to avoid using popular ingredient to prevent 'damage' CEO James Leavesley said: "It's taken four-and-a-half years to actually get to a point where we're fully licensed by the MHRA (Medicines and Healthcare products Regulatory Agency) and the Home Office to cultivate, manufacture and supply medical cannabis in the UK. "Some of the feedback we have received from doctors was that the supply of imported cannabis can be unreliable and with varying quality due to a lack of transparency of the supply chain. So that means that when patients are prescribed medical cannabis they get their repeat prescriptions, often it's not available or out of stock. "If products have to be imported it can take 12 to 20 weeks just to get into the UK. The benefit of being located here in the Midlands, as soon as we finish the growing cycle we harvest and slowly dry our product then pack it. From that moment it can be within a patient's hand inside a month." The plants – which are fed around 12 times every day - are grown in a series of medical-grade laboratories which are constantly air-filtered. The team of expert growers are all issued with specially-made dark glasses due to the powerful LED lighting used to cultivate the crop. James added: 'The lighting has been bespoke-made, and we actually create artificial wind in the room to ensure there are no microclimates.' Each plant takes five months to grow over 6ft in height when they are ready to be harvested. They are then dried and cured to remove any moisture before they are trimmed by hand and their flowers separated. Head grower Brady Green, who joined the company in 2023, said: "Our crop cycle runs about five months in total. About two weeks in the crop propagation stage, about two weeks in veg, and then flowering takes about seven to twelve weeks depending on variety. From there it takes another two weeks to dry and two weeks to cure and a little bit of time to trim. "It's important to discuss medical cannabis openly and break the stigma of this plant. It's the opposite of evil and dangerous and hopefully it can provide a lot of assistance for people." Last September the company secured their second licence, giving them permission to sell their product. The company shipped its first batch of 500 prescriptions worth of medical cannabis last month.
Yahoo
07-02-2025
- Business
- Yahoo
Inside secret £10m medicinal cannabis factory - guarded by ex-soldiers
A £10 million medical cannabis facility in the Midlands, run by Derbyshire-based Dalgety, is the first in the UK with EU GMP certification to cultivate, manufacture, and distribute high-grade cannabinoids. The 30,000 sq ft site, protected by ex-military guards and 150 security cameras, ensures a consistent domestic supply of prescription cannabis, addressing shortages caused by international imports. CEO James Leavesley said their process delivers products to patients in weeks. Dalgety's first shipment, equivalent to 500 prescriptions, was sent out last month as the firm seeks to break the stigma surrounding medical cannabis.
